Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Paris  >  Pharmagest Interactive    PHA   FR0012882389

PHARMAGEST INTERACTIVE

(PHA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

PHARMAGEST ITALIA accelerates its geographical expansion in Italy: acquisition of SVEMU

share with twitter share with LinkedIn share with facebook
share via e-mail
10/02/2019 | 03:33am EST

Villers-lès-Nancy, 2 October 2019 - 7:00 a.m. (CET)

PRESS RELEASE

PHARMAGEST ITALIA accelerates its geographical

expansion in Italy: acquisition of SVEMU

  • Acquisition of a majority stake in the capital of SVEMU INFORMATICA FARMACEUTICA.
  • An Italian company specialised in pharmacy IT solutions with an installed base of 800 pharmacies throughout Italy.
  • An acquisition in line with the strategy implemented by Pharmagest Group in this country to:
    o Rapidly expand PHARMAGEST ITALIA's regional coverage in Italy; o Bolster SOPHIA's technical and technological offering.

***

Pharmagest Grouptoday announces the completion of the acquisition by PHARMAGEST ITALIA of an 80% majority stake in the capital of SVEMU, a specialised provider of IT solutions for pharmacies in the Italian market.

Created in June 2008, SVEMUis an independent software vendor known for its innovative pharmacy management solutions. Its EasyPharma application equips more than 800 of Italy's 19,000 pharmacies in 13 regions of country.

Featuring a very comprehensive range of functionalities and services, EasyPharma's proven and high-performance technology is perfectly adapted to both the configuration of the Italian market and developments in the Italian healthcare market.

This acquisition completes the technological and technical building blocks that were missing from PHARMAGEST ITALIA's SOPHIA software suite (the Italian equivalent of LGPI Global Services®).

As a new market entrant, PHARMAGEST ITALIA will be able to build on SVEMU's installed base and consolidate its market positions by rapidly completing its territorial coverage in Italy in order to reach its goal of equipping nearly 20% of Italian pharmacies within five years.

Financial calendar:

  • Participation in the MidCap Event in Paris on Monday 14 October 2019.
  • Publication of Q3 2019 sales: 15 November 2019 (after the close of trading).
  • Publication of FY 2019 annual sales: 14 February 2020 (after the close of trading).

Press Release 2 October 2019 - New acquisition in Italy - SVEMU - 2

About Pharmagest Group:

Pharmagest Group is the French pharmacy information technology leader, with a market share of more than 44% and nearly 1,000 employees. The Group's strategy is based on a core business of improving healthcare through information technology innovation and developing two priority areas: 1/ Services and technologies for healthcare professionals, with a focus on assisting pharmacies in patient medication compliance; and 2/ technologies for improving the efficacy of healthcare systems.

This strategy is executed through specialised business lines developed by Pharmagest Group: pharmacy IT solutions, e-Health solutions, solutions for healthcare professionals, hospital solutions, solutions for pharmaceutical laboratories, connected health devices and apps, and a sales financing marketplace...

These businesses are grouped within four divisions: Pharmacy - Europe Solutions; Health and Social Care Facilities Solutions; e- Health Solutions and Fintech.

Listed on Euronext Paris™ - Compartment B

Indices: CAC® SMALL and CAC® All-Tradable par inclusion

Eligible for the Long-Only Deferred Settlement Service (SRD)

ISIN: FR 0012882389 - Reuters: PHA.PA - Bloomberg: - PMGI FP

For all the latest news go to www.pharmagest.com

Follow Pharmagest on Twitter: @Pharmagest, Linkedinand Facebook

CONTACTS

Media Relations:

FIN'EXTENSO - Isabelle APRILE

Tel. +33 (0)1 39 97 61 22 - i.aprile@finextenso.fr

Disclaimer

Pharmagest Interactive SA published this content on 02 October 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 02 October 2019 07:32:10 UTC

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on PHARMAGEST INTERACTIVE
02/06PHARMAGEST INTERACTIVE : FY 2019 Revenue
PU
2019PHARMAGEST INTERACTIVE : 3rd quarter earnings
CO
2019PHARMAGEST INTERACTIVE : Group wins the top prize in its category of the 2019 GA..
PU
2019PHARMAGEST INTERACTIVE : MALTA INFORMATIQUE expands the coverage of its services..
PU
2019PHARMAGEST ITALIA ACCELERATES ITS GE : acquisition of SVEMU
PU
2019PHARMAGEST INTERACTIVE : H1 2019 results
PU
2019PHARMAGEST INTERACTIVE : H1 2019 revenue
PU
2019PHARMAGEST INTERACTIVE : H1 2019 revenue
AQ
2019PHARMAGEST INTERACTIVE : 2nd quarter earnings
CO
2019PHARMAGEST INTERACTIVE : Ex-dividend day for final dividend
FA
More news
Financials (EUR)
Sales 2020 172 M
EBIT 2020 47,5 M
Net income 2020 33,2 M
Finance 2020 65,8 M
Yield 2020 1,70%
P/E ratio 2020 26,9x
P/E ratio 2021 24,2x
EV / Sales2020 4,89x
EV / Sales2021 4,40x
Capitalization 905 M
Chart PHARMAGEST INTERACTIVE
Duration : Period :
Pharmagest Interactive Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PHARMAGEST INTERACTIVE
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Average target price 71,80  €
Last Close Price 60,30  €
Spread / Highest target 22,7%
Spread / Average Target 19,1%
Spread / Lowest Target 15,4%
EPS Revisions
Managers
NameTitle
Dominique Pautrat Chief Executive Officer, Director & Head-Pharmacy
Thierry Chapusot Chairman & Investor Relations Contact
Denis Serge Claude Supplisson Chief Operating Officer, Deputy GM& Director
Jean-Yves Samson Chief Financial Officer & Head-Investor Relations
Damien Maringer Technical Director-Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
PHARMAGEST INTERACTIVE-0.50%985
ORACLE CORPORATION-3.81%168 883
SAP AG-0.86%157 080
INTUIT INC.8.73%74 560
SERVICENOW, INC.16.79%63 310
CONSTELLATION SOFTWARE INC.13.64%22 451